Total Payments
$5,555
2024 Payments
$171.51
Companies
12
Transactions
41
Medicare Patients
1,110
Medicare Billing
$166,692
Payment Breakdown by Category
Travel$3,118 (56.1%)
Food & Beverage$2,437 (43.9%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Travel and Lodging | $3,118 | 6 | 56.1% |
| Food and Beverage | $2,437 | 35 | 43.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| F. Hoffmann-La Roche AG | $3,129 | 6 | $0 (2018) |
| Novartis Pharmaceuticals Corporation | $1,301 | 6 | $0 (2018) |
| Lilly USA, LLC | $408.97 | 10 | $0 (2024) |
| ACADIA Pharmaceuticals Inc | $187.55 | 10 | $0 (2023) |
| PORTOLA PHARMACEUTICALS, INC. | $132.48 | 1 | $0 (2019) |
| Takeda Pharmaceuticals U.S.A., Inc. | $123.61 | 1 | $0 (2022) |
| Teva Pharmaceuticals USA, Inc. | $108.00 | 1 | $0 (2022) |
| Eli Lilly and Company | $62.31 | 1 | $0 (2017) |
| Avanir Pharmaceuticals, Inc. | $36.79 | 2 | $0 (2018) |
| GE HealthCare | $32.61 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $171.51 | 6 | Lilly USA, LLC ($154.53) |
| 2023 | $123.76 | 3 | Lilly USA, LLC ($100.22) |
| 2022 | $425.56 | 6 | Lilly USA, LLC ($139.83) |
| 2021 | $61.34 | 4 | ACADIA Pharmaceuticals Inc ($45.90) |
| 2020 | $54.10 | 3 | ACADIA Pharmaceuticals Inc ($54.10) |
| 2019 | $153.55 | 2 | PORTOLA PHARMACEUTICALS, INC. ($132.48) |
| 2018 | $1,895 | 6 | F. Hoffmann-La Roche AG ($1,735) |
| 2017 | $2,670 | 11 | F. Hoffmann-La Roche AG ($1,394) |
All Payment Transactions
41 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/10/2024 | Lilly USA, LLC | AMYVID (Drug), KISUNLA | Food and Beverage | In-kind items and services | $6.76 | General |
| Category: Neuroscience | ||||||
| 08/21/2024 | Lilly USA, LLC | KISUNLA (Drug) | Food and Beverage | In-kind items and services | $6.04 | General |
| Category: Neuroscience | ||||||
| 08/21/2024 | Lilly USA, LLC | KISUNLA (Drug) | Food and Beverage | In-kind items and services | $4.03 | General |
| Category: Neuroscience | ||||||
| 08/09/2024 | ABBVIE INC. | DUOPA (Drug) | Food and Beverage | In-kind items and services | $16.98 | General |
| Category: NEUROSCIENCE | ||||||
| 07/24/2024 | Lilly USA, LLC | KISUNLA (Drug) | Food and Beverage | In-kind items and services | $45.68 | General |
| Category: Neuroscience | ||||||
| 03/05/2024 | Lilly USA, LLC | — | Food and Beverage | In-kind items and services | $92.02 | General |
| 07/19/2023 | Lilly USA, LLC | — | Food and Beverage | In-kind items and services | $15.10 | General |
| 03/16/2023 | Lilly USA, LLC | AMYVID (Drug) | Food and Beverage | In-kind items and services | $85.12 | General |
| Category: Neuroscience | ||||||
| 03/10/2023 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $23.54 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 11/02/2022 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $108.00 | General |
| Category: Central Nervous System | ||||||
| 10/17/2022 | Lilly USA, LLC | — | Food and Beverage | In-kind items and services | $60.90 | General |
| 09/08/2022 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $21.51 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 08/16/2022 | Lilly USA, LLC | AMYVID (Drug), Tauvid | Food and Beverage | In-kind items and services | $78.93 | General |
| Category: Neuroscience | ||||||
| 08/11/2022 | GE HealthCare | — | Food and Beverage | Cash or cash equivalent | $32.61 | General |
| 05/28/2022 | Takeda Pharmaceuticals U.S.A., Inc. | GAMMAGARD (Biological) | Food and Beverage | In-kind items and services | $123.61 | General |
| Category: IMMUNOLOGY | ||||||
| 09/09/2021 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $12.13 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 08/24/2021 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $12.25 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 07/12/2021 | Biogen, Inc. | ADUHELM (Biological) | Food and Beverage | In-kind items and services | $15.44 | General |
| Category: NEUROLOGY | ||||||
| 02/01/2021 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $21.52 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 12/16/2020 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $18.94 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 10/22/2020 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $11.38 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 08/06/2020 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $23.78 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 10/29/2019 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $21.07 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 02/19/2019 | PORTOLA PHARMACEUTICALS, INC. | ANDEXXA (Biological) | Food and Beverage | In-kind items and services | $132.48 | General |
| Category: HEMATOLOGY/NEUROLOGY | ||||||
| 10/18/2018 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $123.13 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 328 | 383 | $154,579 | $47,711 |
| 2022 | 3 | 295 | 340 | $139,592 | $42,603 |
| 2021 | 3 | 244 | 299 | $128,198 | $41,417 |
| 2020 | 5 | 243 | 304 | $134,285 | $34,961 |
Total Patients
1,110
Total Services
1,326
Medicare Billing
$166,692
Procedure Codes
15
All Medicare Procedures & Services
15 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 101 | 101 | $48,379 | $16,360 | 33.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 120 | 158 | $50,503 | $15,031 | 29.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 96 | 113 | $51,528 | $14,942 | 29.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 11 | 11 | $4,169 | $1,378 | 33.1% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 105 | 105 | $50,295 | $17,548 | 34.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 96 | 114 | $51,984 | $14,383 | 27.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 94 | 121 | $37,313 | $10,672 | 28.6% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 115 | 166 | $75,696 | $22,303 | 29.5% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 88 | 88 | $42,152 | $14,482 | 34.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 41 | 45 | $10,350 | $4,632 | 44.8% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 117 | 177 | $80,712 | $19,029 | 23.6% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Office | 2020 | 78 | 78 | $37,095 | $11,958 | 32.2% |
| 99354 | Prolonged office or other outpatient service first hour | Office | 2020 | 13 | 14 | $4,060 | $1,491 | 36.7% |
| 70551 | Mri scan brain | Office | 2020 | 24 | 24 | $9,888 | $1,490 | 15.1% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 11 | 11 | $2,530 | $993.50 | 39.3% |
About Dr. David Hunter, M.D
Dr. David Hunter, M.D is a Neurology healthcare provider based in Houston, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/23/2012. The National Provider Identifier (NPI) number assigned to this provider is 1508111808.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Hunter, M.D has received a total of $5,555 in payments from pharmaceutical and medical device companies, with $171.51 received in 2024. These payments were reported across 41 transactions from 12 companies. The most common payment nature is "Travel and Lodging" ($3,118).
As a Medicare-enrolled provider, Hunter has provided services to 1,110 Medicare beneficiaries, totaling 1,326 services with total Medicare billing of $166,692. Data is available for 4 years (2020–2023), covering 15 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Other Specialties Behavioral Neurology & Neuropsychiatry
- Location Houston, TX
- Active Since 07/23/2012
- Last Updated 09/20/2017
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1508111808
Products in Payments
- Non-Covered Product (Drug) $3,129
- CNP520 (Drug) $847.74
- NUPLAZID (Drug) $187.55
- AMYVID (Drug) $185.20
- ANDEXXA (Biological) $132.48
- GAMMAGARD (Biological) $123.61
- AUSTEDO (Drug) $108.00
- KISUNLA (Drug) $55.75
- NUEDEXTA (Drug) $36.79
- DUOPA (Drug) $16.98
- ADUHELM (Biological) $15.44
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Houston
William Ondo, M.d, M.D
Neurology — Payments: $1.5M
Neurology $1.5M
Dr. Annette Howard, Md, MD
Neurology — Payments: $1.2M
Neurology $1.2M
Paul Schulz, M.d, M.D
Neurology — Payments: $943,067
Neurology $943,067
Amit Verma, Md, MD
Neurology — Payments: $817,815
Neurology $817,815
Dr. Randolph Evans, Md, MD
Neurology — Payments: $715,948
Neurology $715,948
Dr. John Volpi, Md, MD
Neurology — Payments: $569,676
Neurology $569,676